Case Study: Global Pharma Company strengthens rare disease intelligence and competitive advantage with Contify

Pharma Company Monitors Competitors’ Rare Disease Portfolio Developments to Identify Opportunities and Threats Using Contify

Global Pharma Company, a global pharmaceutical leader focused on rare diseases, needed a single source of truth for market and competitive intelligence. Before working with Contify, teams struggled with information silos, manual research overload, and scattered data from news, reports, social media, and other sources. The company used Contify’s Market & Competitive Intelligence Platform to better track competitors’ rare disease portfolio developments and identify both opportunities and threats.

Contify built a tailored intelligence setup with custom taxonomy, curated newsfeeds, email alerts, segmented newsletters, customized dashboards for research, development, and market access teams, and Microsoft Teams integration. As a result, Global Pharma Company gained a more comprehensive view of the competitive landscape, accelerated R&D decision-making, improved commercial and market access actions, and strengthened its leadership position in rare diseases. The case study does not provide exact numerical metrics, but it reports faster response times, reduced redundant research, and more strategic, proactive launches and collaborations.